Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celcuity Inc.CELC · Entity 3991 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celcuity Inc.
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,530 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 1,530 · Balance 1,530 F1: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027. |
| Common StockSEC Table I · non-derivative | IndirectBy Brightstone Venture Capital Fund, LP | 65,000 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 65,000 F2: The reporting person is the General Partner of Brightstone. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.
F2: The reporting person is the General Partner of Brightstone.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 9, 2026 22:24 UTC | Celcuity Inc. CELC · Entity 3991 | GrantCommon Stock | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001296457-26-000008 · form4-06092026_100607.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,530 F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:31 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 25,000 | $140.68 | $3,517,000.00 |
DisclosureSEC source: 0001296457-26-000006 · form4-05062026_080550.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 65,000 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP ("Brightstone") on August 19, 2025. F2 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:31 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 20,000 | $120.03 | $2,400,538.00 |
DisclosureSEC source: 0001296457-26-000003 · form4-01292026_090151.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 90,000 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP ("Brightstone") on August 19, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.315, inclusive. The reporting person undertakes to provide Celcuity Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 21:07 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 15,000 | $100.00 | $1,500,016.50 |
DisclosureSEC source: 0001296457-25-000004 · form4-11242025_091156.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 110,000 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP ("Brightstone") on August 19, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.03, inclusive. The reporting person undertakes to provide Celcuity Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 4,141 | $46.05 | $190,693.05 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 7 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 125,000 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F6 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 16,438 | $45.29 | $744,454.01 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 6 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 129,141 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.99 to $45.76, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 22,377 | $44.36 | $992,598.97 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 5 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 145,579 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.97 to $44.96, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 57,044 | $43.30 | $2,469,856.89 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 4 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 167,956 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.94 to $43.90, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: The reporting person is the General Partner of Brightstone. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 2,025 | $46.05 | $93,251.45 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 3 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.05 to $46.06, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 4,163 | $45.24 | $188,343.69 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 2 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,025 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.855, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 3,137 | $44.36 | $139,171.75 |
DisclosureSEC source: 0001415889-25-020570 · form4-07302025_080741.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,188 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Brightstone Venture Capital Fund, LP ("Brightstone") on December 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.99 to $44.96, inclusive. The reporting person undertakes to provide Celcuity Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC") upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:49 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 14,048 | $0.00 Strike: $10.69 | $0.00 |
DisclosureSEC source: 0001415889-25-013950 · form4-05212025_080532.xml · derivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,048 Underlying: Common Stock · 14,048 shares Expires 2035-05-19 F1 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2026, or if earlier, the date of the Company's 2026 Annual Meeting of Stockholders. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:18 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 8,153 | $0.00 Strike: $14.83 | $0.00 |
DisclosureSEC source: 0001062993-24-012040 · form4.xml · derivative · entry 10 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,153 Underlying: Common Stock · 8,153 shares Expires 2034-06-04 F3 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2025, or if earlier, the date of the Company's 2025 Annual Meeting of Stockholders. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:43 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 2,940 | $14.57 | $42,847.27 |
DisclosureSEC source: 0001062993-23-022759 · form4.xml · nonDerivative · entry 2 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 225,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $14.75, inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:43 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 5,000 | $14.75 | $73,751.50 |
DisclosureSEC source: 0001062993-23-022759 · form4.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 227,940 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.75 to $15.00, inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP. Read SEC document |
| December 13, 2023 Filed Dec 14, 2023 23:05 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 5,000 | $14.50 | $72,500.00 |
DisclosureSEC source: 0001062993-23-022590 · form4.xml · nonDerivative · entry 2 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 232,940 F2 · ownership.nature: The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 23:05 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 2,060 | $14.61 | $30,089.18 |
DisclosureSEC source: 0001062993-23-022590 · form4.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 237,940 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.66, inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP. Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 21:19 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 5,000 | $15.00 | $75,000.00 |
DisclosureSEC source: 0001062993-23-022328 · form4.xml · nonDerivative · entry 2 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 240,000 F1 · ownership.nature: The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:19 UTC | Celcuity Inc. CELC · Entity 3991 | SaleCommon Stock | 5,000 | $14.85 | $74,250.00 |
DisclosureSEC source: 0001062993-23-022328 · form4.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Brightstone Venture Capital Fund, LP Disclosed balance after: 245,000 F1 · ownership.nature: The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:18 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 11,645 | $0.00 Strike: $9.58 | $0.00 |
DisclosureSEC source: 0001062993-23-011366 · form4.xml · derivative · entry 9 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,645 Underlying: Common Stock · 11,645 shares Expires 2033-05-15 F3 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 24,449 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 12 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,449 Underlying: Common Stock · 24,449 shares Expires 2032-05-17 F4 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 2,310 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 11 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 2,310 | Not disclosed Strike: $26.99 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 10 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 8 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 5,054 | Not disclosed Strike: $22.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 7 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,201 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 6 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,201 Underlying: Common Stock · 3,201 shares Expires 2028-05-14 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 3,201 | Not disclosed Strike: $19.45 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 5 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2028-05-14 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 8,200 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 4 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:41 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 8,200 | Not disclosed Strike: $16.23 | Not disclosed |
DisclosureSEC source: 0001437749-22-013130 · rdgdoc.xml · derivative · entry 3 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F2 · derivative.exercise_date: 100% vested. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:02 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 2,310 | $0.00 Strike: $26.99 | $0.00 |
DisclosureSEC source: 0000914190-21-000157 · edgar.xml · derivative · entry 7 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2031-05-12 F4 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2022, or if earlier, the date of the Company's 2022 Annual Meeting of Stockholders. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:02 UTC | Celcuity Inc. CELC · Entity 3991 | GrantCommon Stock | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-21-000157 · edgar.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,325 F1 · shares: Represents 1,482 shares of restricted stock for which risks of forfeiture lapse on April 30, 2022, or if earlier, the date of the Company's 2022 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:27 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 12,654 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0000914190-20-000176 · edgar.xml · derivative · entry 6 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,654 Underlying: Common Stock · 12,654 shares Expires 2030-05-14 F4 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2021, or if earlier, the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:27 UTC | Celcuity Inc. CELC · Entity 3991 | GrantCommon Stock | 7,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-20-000176 · edgar.xml · nonDerivative · entry 1 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,843 F1 · shares: Represents 7,843 shares of restricted stock for which risks of forfeiture lapse on April 30, 2021, or if earlier, the date of the Company's 2021 Annual Meeting of Stockholders. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:04 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 5,054 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0000914190-19-000178 · edgar.xml · derivative · entry 4 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F3 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2020, or if earlier, the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2018 Filed May 16, 2018 20:48 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,201 | $0.00 Strike: $19.45 | $0.00 |
DisclosureSEC source: 0000914190-18-000204 · edgar.xml · derivative · entry 3 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,201 Underlying: Common Stock · 3,201 shares Expires 2028-05-14 F2 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2019, or if earlier, the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:20 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 8,200 | $0.00 Strike: $16.23 | $0.00 |
DisclosureSEC source: 0000914190-17-000332 · edgar.xml · derivative · entry 2 Dalvey David · CIK 0001296457 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires 2027-10-19 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.